BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Merrimack Pharmaceuticals Inc. 

101 Binney Street

Cambridge  Massachusetts  02142  U.S.A.
Phone: 617-441-1000 Fax: 617-491-1386


SEARCH JOBS

View Clinical Trials from BioPharm Insight




Segment
Start Up

Collaborations

Dyax Corp.  Antibody phage display





 Company News
Merrimack (MACK) To Highlight Extensive Oncology Pipeline At The 2015 American Association for Cancer Research Annual Meeting 3/26/2015 1:23:35 PM
1,075 New Jobs to be Added by 11 Life Science Firms in Massachusetts: Amgen (AMGN), Alnylam (ALNY), Biogen Idec, Inc. (North Carolina) (BIIB), GE Healthcare Bio-Sciences, Quest Diagnostics (DGX), Alkermes (ALKS), Baxter Healthcare (BAX), Merrimack (MACK), Synageva BioPharma (GEVA), Philips Electronics, SMC 3/19/2015 6:51:59 AM
Advanced Cell Diagnostics, Inc.' RNAscope Technology Supports Biomarker-Selected Phase 2 Clinical Trial Of Merrimack Pharmaceuticals Inc. (MACK)' MM-121 3/9/2015 6:36:47 AM
Merrimack Pharmaceuticals Inc. (MACK) Reports Fourth Quarter 2014 Financial Results 2/26/2015 1:22:04 PM
Merrimack Pharmaceuticals Inc. (MACK) Announces Initiation Of A Phase 2 Biomarker-Selected Clinical Trial Of MM-121 In Patients With Heregulin Positive Non-Small Cell Lung Cancer 2/19/2015 7:35:36 AM
Merrimack Pharmaceuticals Inc. (MACK) Announces Timing Of Fourth Quarter 2014 Investor Conference Call 2/12/2015 7:49:15 AM
Merrimack Pharmaceuticals Inc. (MACK) Names Birgit M. Schoeberl, Ph.D. As Head Of Discovery Division And Announces The Addition Of Ulrik B. Nielsen, Ph.D. To Its Board Of Directors 1/23/2015 7:39:11 AM
Merrimack (MACK) Presents Additional Analyses Of Phase 3 MM-398 NAPOLI-1 Study At The ASCO 2015 Gastrointestinal Cancers Symposium 1/20/2015 6:53:46 AM
Merrimack Pharmaceuticals Inc. (MACK) Announces Oral Presentation Of Additional Analyses Of MM-398 Phase 3 NAPOLI-1 Study At The American Society of Clinical Oncology 2015 Gastrointestinal Cancers Symposium 1/8/2015 7:50:22 AM
Merrimack Pharmaceuticals Inc. (MACK) To Present At The 33rd Annual J.P. Morgan Healthcare Conference 1/7/2015 10:06:04 AM
12345678910...